Image

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Studying AML relapse after stem cell transplant for better understanding.

Recruiting
18 years and older
All
Phase N/A

This study looks at patients with acute myeloid leukemia (AML) who have had a stem cell transplant, which is a procedure to replace damaged blood-forming cells. Doctors are trying to see if a test called measurable residual disease (MRD), which checks for tiny amounts of cancer, can help predict if the cancer might come back and how long patients might live. The study will last about 7 years, with people participating for about 3 years. During this time, up to 1,000 people will be asked to give blood samples at specific times after their transplant. They might also need to give bone marrow samples, which are taken from inside the bone.

  • The study involves blood samples at 10 different times over 18 months and possibly more if cancer returns.
  • Participants must be at least 18 years old, in complete remission from AML, and have not had a previous stem cell transplant.
  • Participation is voluntary, and participants must agree to follow all study procedures for about 3 years.
Study details
    Acute Myeloid Leukemia in Remission

NCT05224661

Center for International Blood and Marrow Transplant Research

17 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.